ESC Guidelines 2389 disclosure forms are kept on file at the European Heart House,
headquarters of the ESC. Any changes in conflict of interest that arise during the writing …

for digital applications (smartphones, etc.). These versions are abridged and thus, for more
detailed information, the user should always access to the full text version of the guidelines …

In this position statement of the ESC Working Group on Myocardial and Pericardial Diseases
an expert consensus group reviews the current knowledge on clinical presentation …

The content of these European Society of Cardiology (ESC) Guidelines has been published
for personal and educational use only. No commercial use is authorized. No part of the ESC …

Background Transthyretin amyloid cardiomyopathy is caused by the deposition of
transthyretin amyloid fibrils in the myocardium. The deposition occurs when wild-type or …

Background—Diffuse myocardial fibrosis is a final end point in most cardiac diseases. It is
missed by the cardiovascular magnetic resonance (CMR) late gadolinium enhancement …

In this paper the Working Group on Myocardial and Pericardial Disease proposes a revised
definition of dilated cardiomyopathy (DCM) in an attempt to bridge the gap between our …

Objectives: We investigated the significance of fibrosis detected by late gadolinium
enhancement cardiovascular magnetic resonance for the prediction of major clinical events …

Aims Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden cardiac death
(SCD) in young adults. Current risk algorithms provide only a crude estimate of risk and fail …

OBJECTIVES We sought to identify patients with hypertrophic cardiomyopathy (HCM) at
high risk of sudden death (SD). BACKGROUND Relatively low mortality rates in HCM make …